Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
STAARVISC-II
- Development stage
- Unknown
- Lead developer
- Staar Surgical
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
STAARVISC-II is a cohesive ophthalmic viscosurgical device (OVD) containing 1.2% high molecular weight sodium hyaluronate, developed by STAAR Surgical. It is primarily indicated for use during anterior segment ophthalmic procedures, such as cataract extraction and intraocular lens (IOL) implantation. The substance acts as a mechanical lubricant and space-filler, maintaining the depth of the anterior chamber and providing a clear surgical field. Its high viscosity under low shear rates protects the delicate corneal endothelial cells and other intraocular tissues from mechanical trauma caused by surgical instruments or IOL contact. Due to its cohesive nature, STAARVISC-II can be easily and completely aspirated from the eye at the conclusion of the surgery, which helps to minimize the risk of postoperative intraocular pressure spikes.
- Brand names
- STAARVISC-II
- Other names
- sodium hyaluronate
Beyond the preview
Go deeper on STAARVISC-II.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on STAARVISC-II.